The pharmaceutical industry is witnessing a significant evolution in oral solid dosage (OSD) development, driven by an increasing demand for…
Read More
New Research from University of Illinois Identifies Glycan-Based Method to Extend Sperm Viability and Improve IVF Success Rates
The field of reproductive medicine has reached a significant milestone as researchers at the University of Illinois Urbana-Champaign have documented…
Read More
Lilly Emerges as Top Pharma Company by Revenue in FY2025, Fueled by Mounjaro and Zepbound’s $36.5 Billion Success
Eli Lilly and Company has officially concluded its fiscal year 2025 as the world’s leading pharmaceutical enterprise by revenue, a…
Read More
Innovations in Oviduct Glycan Technology Enhance Sperm Viability and In Vitro Fertilization Success
Researchers at the University of Illinois Urbana-Champaign have pioneered a novel methodology for selecting and preserving viable sperm during the…
Read More
University of Illinois Researchers Discover Glycan-Based Method to Extend Sperm Viability and Improve In Vitro Fertilization Success
The process of in vitro fertilization (IVF) has long been a cornerstone of both human reproductive medicine and industrial animal…
Read More
University of Illinois Researchers Discover Glycan-Based Method to Extend Sperm Viability and Improve IVF Success Rates
The University of Illinois Urbana-Champaign has unveiled a transformative approach to In Vitro Fertilization (IVF) by leveraging the natural biochemical…
Read More
Breakthrough in IVF Research Uses Oviduct Glycans to Extend Sperm Viability and Improve Embryo Success Rates
In vitro fertilization (IVF) has long been a cornerstone of both human reproductive medicine and global agricultural productivity. However, despite…
Read More
Navigating the Biotech Frontier: Investors Reveal Keys to Startup Success at Advanced Therapies Conference
The pursuit of groundbreaking innovation in advanced therapeutic medicinal products (ATMPs) is a high-stakes endeavor, particularly for early-stage biotech startups…
Read MoreYOU MAY HAVE MISSED
